Pharmacotherapy of heart failure in the elderly: adverse events. - Wikidata - awgldk - TriplyDB

Pharmacotherapy of heart failure in the elderly: adverse events.

Pharmacotherapy of heart failure in the elderly: adverse events.

http://www.wikidata.org/entity/Q37891877

about

Management of chronic heart failure in the older population.Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF.Heart failure in elderly: progress in clinical evaluation and therapeutic approach.The older patient with heart failure: high risk for frailty and cognitive impairment.Polypharmacy in heart failure patients.Acute Decompensated Heart Failure.Strategies to improve self-management in heart failure patients.YiQiFuMai injection for chronic heart failure: Protocol for a systematic review and meta-analysis.Effect of various Danshen injections on patients with coronary heart disease after percutaneous coronary intervention: A protocol for a systematic review and network meta-analysis.

P2860

Q34930544-DEFA3822-AEFD-4F10-8010-1E776018EFB0 Q36128797-EEA8B73C-B2F5-4DEE-B4A5-AD4A81E53A12 Q37001576-CE61EBA1-4060-488E-A25F-7C38D5FF0E54 Q38034810-E248B8F4-2A7E-4895-A877-9763BD3D4E45 Q38184967-92C520BD-0885-4A1B-8EAB-02D75EF73204 Q38957219-688F78BD-9F34-49F1-928A-F59E2402A83B Q39115177-CD4BB739-7857-46ED-BACB-5772F428D208 Q49711980-2447C1B3-7F8D-4A1F-B1AF-A4DED809907F Q55422733-FA5643F7-40F9-4F65-B260-E6AC20BF48F5

P2860

Pharmacotherapy of heart failure in the elderly: adverse events.

http://www.wikidata.org/entity/Q37891877

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacotherapy of heart failure in the elderly: adverse events.

@en

Pharmacotherapy of heart failure in the elderly: adverse events.

@nl

type

label

Pharmacotherapy of heart failure in the elderly: adverse events.

@en

Pharmacotherapy of heart failure in the elderly: adverse events.

@nl

prefLabel

Pharmacotherapy of heart failure in the elderly: adverse events.

@en

Pharmacotherapy of heart failure in the elderly: adverse events.

@nl

P1433

Q37891877-95769F68-215F-40D0-9005-713AFE95085D

P1476

Q37891877-56C73515-2369-4AF9-95F2-513D4FF75427

P2093

Q37891877-2610097C-BEDD-417E-BADB-D9E9596F88FB

P2860

Q37891877-06EB5BCB-FF57-410F-B90E-A6E4AD1C9FA4

Q37891877-0880D08E-E6AA-4F6D-B904-743A8FE9EC90

Q37891877-0F32E9C2-0CAD-452C-81A1-56243296A40B

Q37891877-1BDD9735-DCEF-46D1-95CC-7EF1DCDEDF93

Q37891877-1FC329CB-D9C0-4E25-9DCC-C13253F36CEF

Q37891877-30C2F64B-8CE6-4D57-AE0D-98296AC1DF0C

Q37891877-31896576-ED52-47B5-98A4-E3E488FD51CB

Q37891877-3384EB91-A818-42A2-B7CD-AAB438A96F7B

Q37891877-33A00211-87EA-43BE-9795-44782FB10061

Q37891877-3A3EE272-0B23-499F-8F48-D84DDA112D9C

P2888

Q37891877-111A165E-4959-4AD2-93A9-F550422E4CE7

P304

Q37891877-2EC09899-EC92-48F3-85C1-7B36B6E4B9E8

P31

Q37891877-3C428921-BD91-43A8-944A-070D965CCF72

P356

Q37891877-2F37477B-8555-4C54-8017-B0F030C89A1F

P433

Q37891877-3EAD6F24-E4EA-4254-BD23-BC03CE2175A7

P478

Q37891877-9E2921B6-0F21-4A49-BD4F-36399CFD3E58

P577

Q37891877-4B78AAB8-9629-411F-9F19-492002FE67BB

P698

Q37891877-1E3A28BA-0E4A-415E-9E68-BC1D4B6BF958

P921

Q37891877-902411AC-A132-44C5-A0A0-191C0E9FE5D4

Q37891877-FC5F0E77-A586-4AF5-A33C-979152CEA1EC

P356

S10741-011-9263-1

P1433

Heart Failure Reviews

P1476

Pharmacotherapy of heart failure in the elderly: adverse events.

@en

P2093

Michael W Rich

http://www.w3.org/2001/XMLSchema#string

P2860

Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

Chronic kidney disease in the elderly--how to assess risk

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Prediction of creatinine clearance from serum creatinine

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.

Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study.

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications.

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

P2888

s10741-011-9263-1

P304

589-595

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10741-011-9263-1

http://www.w3.org/2001/XMLSchema#string

P433

4-5

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21688185

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy